UB Paderborn / Katalog / Suche / in CDI

Chikungunya virus infection, Brazzaville, Republic of Congo, 2011

Emerging infectious diseases, 2013-09, Vol.19 (9), p.1542-1543

2013

Volltextzugriff (PDF)

Tele-rehabilitation service delivery: Journey from prototype to robust in-home use

2015 International Conference on Virtual Rehabilitation (ICVR), 2015, p.178-182

2015

Volltextzugriff (PDF)

Evaluation of a Tele-Health System for upper extremity stroke rehabilitation

2013 International Conference on Virtual Rehabilitation (ICVR), 2013, p.80-86

2013

Volltextzugriff (PDF)

Dynamic Beat-to-Beat QT-RR Relationship During Physiotherapy Effort in Elderly Patients Without Primary Heart Disease

Pacing and clinical electrophysiology, 1999-08, Vol.22 (8), p.1240-1244

1999

Volltextzugriff (PDF)

Effect of a secondary task on the time course and specificity on learning a balance skill

2013 International Conference on Virtual Rehabilitation (ICVR), 2013, p.283-288

2013

Volltextzugriff (PDF)

Virtual Environments for the study of the effect of context on dual tasking

2009 Virtual Rehabilitation International Conference, 2009, p.211-211

2009

Volltextzugriff (PDF)

Postural adjustments as an acquired motor skill: Delayed gains and robust retention after a single training session within a virtual environment

2008 Virtual Rehabilitation, 2008, p.50-53

2008

Volltextzugriff (PDF)

No transfer of gains after a single training session within a virtual environment to fundamental tests of stability

2009 Virtual Rehabilitation International Conference, 2009, p.136-139

2009

Volltextzugriff (PDF)

Role of phospholipase A2 receptor 1 antibody level at diagnosis for long-term renal outcome in membranous nephropathy

PloS one, 2019-09, Vol.14 (9), p.e0221293-e0221293

2019

Volltextzugriff (PDF)

Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy

Frontiers in immunology, 2018-12, Vol.9, p.3035-3035

2018

Volltextzugriff (PDF)

Frequency of pain crises in sickle cell anemia and its relationship with the sympatho-vagal balance, blood viscosity and inflammation

Haematologica (Roma), 2011-11, Vol.96 (11), p.1589-1594

2011

Volltextzugriff (PDF)

Commensal Escherichia coli isolates are phylogenetically distributed among geographically distinct human populations

Microbiology (Society for General Microbiology), 2001-06, Vol.147 (Pt 6), p.1671

2001

Volltextzugriff (PDF)

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1

The New England journal of medicine, 2015-08, Vol.373 (8), p.705-713

2015

Volltextzugriff (PDF)

Epidemiological profile of multidrug-resistant and extensively drug-resistant Mycobacterium Tubrculosis among Congolese patients

Annals of clinical microbiology and antimicrobials, 2021-12, Vol.20 (1), p.84-84

2021

Volltextzugriff (PDF)

Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study

The Lancet (British edition), 2014-06, Vol.383 (9936), p.2222-2231

2014

Volltextzugriff (PDF)

Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection

The New England journal of medicine, 2013-11, Vol.369 (19), p.1807-1818

2013

Volltextzugriff (PDF)

Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

The Journal of infectious diseases, 2014-08, Vol.210 (3), p.354-362

2014

Volltextzugriff (PDF)

Spontaneous remission of proteinuria is a frequent event in phospholipase A2 receptor antibody-negative patients with membranous nephropathy

Nephrology, dialysis, transplantation, 2015-11, Vol.30 (11), p.1862-1869

2015

Volltextzugriff (PDF)

An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis

Nephrology, dialysis, transplantation, 2011-08, Vol.26 (8), p.2526-2532

2011

Volltextzugriff (PDF)

Role of phospholipase A.sub.2 receptor 1 antibody level at diagnosis for long-term renal outcome in membranous nephropathy

PloS one, 2019-09, Vol.14 (9), p.e0221293

2019

Volltextzugriff (PDF)

CD4 + T cells produce GM-CSF and drive immune-mediated glomerular disease by licensing monocyte-derived cells to produce MMP12

Science translational medicine, 2023-03, Vol.15 (687), p.eadd6137

2023

Volltextzugriff (PDF)

Glucocorticoids target the CXCL9/CXCL10-CXCR3 axis and confer protection against immune-mediated kidney injury

JCI insight, 2023-01, Vol.8 (1)

2023

Volltextzugriff (PDF)

Evolutionary Implications of the Frequent Horizontal Transfer of Mismatch Repair Genes

Cell, 2000-11, Vol.103 (5), p.711-721

2000

Volltextzugriff (PDF)

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial

The lancet HIV, 2018-05, Vol.5 (5), p.e211-e220

2018

Volltextzugriff (PDF)

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial

The lancet HIV, 2020-01, Vol.7 (1), p.e16-e26

2020

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Chikungunya virus infection, Brazzaville, Republic of Congo, 2011

Tele-rehabilitation service delivery: Journey from prototype to robust in-home use

Evaluation of a Tele-Health System for upper extremity stroke rehabilitation

Dynamic Beat-to-Beat QT-RR Relationship During Physiotherapy Effort in Elderly Patients Without Primary Heart Disease

Effect of a secondary task on the time course and specificity on learning a balance skill

Virtual Environments for the study of the effect of context on dual tasking

Postural adjustments as an acquired motor skill: Delayed gains and robust retention after a single training session within a virtual environment

No transfer of gains after a single training session within a virtual environment to fundamental tests of stability

Role of phospholipase A2 receptor 1 antibody level at diagnosis for long-term renal outcome in membranous nephropathy

Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy

Frequency of pain crises in sickle cell anemia and its relationship with the sympatho-vagal balance, blood viscosity and inflammation

Commensal Escherichia coli isolates are phylogenetically distributed among geographically distinct human populations

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1

Epidemiological profile of multidrug-resistant and extensively drug-resistant Mycobacterium Tubrculosis among Congolese patients

Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study

Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection

Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

Spontaneous remission of proteinuria is a frequent event in phospholipase A2 receptor antibody-negative patients with membranous nephropathy

An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis

Role of phospholipase A.sub.2 receptor 1 antibody level at diagnosis for long-term renal outcome in membranous nephropathy

CD4 + T cells produce GM-CSF and drive immune-mediated glomerular disease by licensing monocyte-derived cells to produce MMP12

Glucocorticoids target the CXCL9/CXCL10-CXCR3 axis and confer protection against immune-mediated kidney injury

Evolutionary Implications of the Frequent Horizontal Transfer of Mismatch Repair Genes

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial

Suchergebnisse filtern